Glucocorticosteroids in football: use and misuse

被引:23
作者
Dvorak, J.
Feddermann, N.
Grimm, K.
机构
[1] Schulthess Clin, FIFA Med Assessment & Res Ctr, Dept Neurol, CH-8008 Zurich, Switzerland
[2] Univ Clin Muenster, Dept Orthopaed, Munster, Germany
[3] FIFA Med Off, Zurich, Switzerland
关键词
D O I
10.1136/bjsm.2006.027599
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Background and objectives: Glucocorticosteroids are widely used in medicine and have shown unchallenged therapeutic potential in several chronic inflammatory and other diseases. They are also widely used in sports medicine for the treatment of conditions such as asthma and acute injuries. In fact, as banned substances, most requests for therapeutic use exemption concern glucocorticosteroids. Nevertheless, their beneficial effect in certain conditions in sports, where inflammation is only a secondary reaction, remains to be validated. This paper aimed to provide a comprehensive review of the literature covering the therapeutic use of glucocorticosteroids since 1977 in conditions ranging from chronic rheumatic illness to peritendinous or intra-articular injection in acute injuries. Methods: Search of the medical literature published between 1977 and 2006 using PubMed. Articles relevant to the question "When and if at all is the use of glucocorticosteroids justified in football?'' were selected and analysed. Results and conclusions: The findings clearly point out that, despite the common use of glucocorticosteroids in acute injuries in sports, there is actually limited evidence of the true benefits of such a practice. Physicians must take the possible adverse effects into consideration. In an athlete with clinically verified asthma, inhalational glucocorticosteroids remain first line therapy. Finally, for the purposes of education and prevention of misuse, it should be stressed that a measurable performance enhancing effect of glucocorticoids could not be proved on the basis of the results of the scientific studies to date.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 64 条
[1]   Complications of plantar fascia rupture associated with corticosteroid injection [J].
Acevedo, JI ;
Beskin, JL .
FOOT & ANKLE INTERNATIONAL, 1998, 19 (02) :91-97
[2]   In whom and how to prevent glucocorticoid-induced osteoporosis [J].
Adachi, JD ;
Papaioannou, A .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (06) :1039-1064
[3]   The chronic painful Achilles and patellar tendon: research on basic biology and treatment [J].
Alfredson, H .
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2005, 15 (04) :252-259
[4]  
Arndt M, 2004, NERVENARZT, V75, P904, DOI 10.1007/s00115-003-1638-7
[5]  
Arslan S, 2001, RHEUMATOL INT, V21, P20
[6]  
Barthel A, 2003, MED KLIN, V98, P283, DOI 10.1007/s00063-003-1258-9
[7]   Soft steroids: a new approach to the treatment of inflammatory airways diseases [J].
Belvisi, MG ;
Hele, DJ .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2003, 16 (06) :321-325
[8]  
BRACKEN MB, 1999, COCHRANE LIB
[9]   Mood symptoms during corticosteroid therapy: A review [J].
Brown, ES ;
Suppes, T .
HARVARD REVIEW OF PSYCHIATRY, 1998, 5 (05) :239-246
[10]   Proposals for prevention and management of steroid-induced osteoporosis in children and adolescents [J].
Brown, JJ ;
Zacharin, MR .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2005, 41 (11) :553-557